Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Guides
Implantable cardioverter-defibrillator
An implantable cardioverter-defibrillator (ICD) is a small battery-powered electrical impulse generator which is implanted in patients who are at risk of sudden cardiac death due to ventricular fibrillation. The device is programmed to detect cardiac arrhythmia and correct it by delivering a jolt of electricity. The links shown on this page feature the key word ′Implantable cardioverter-defibrillator’ in their stories:
FDA approval for subcutaneous implantable defibrillator
Approvals have been given allowing patients to receive treatment using implantable defibrillator equipment from Boston Scientific
Pacemaker CE mark with options for magnetic resonance imaging (MRI)
Boston Scientific Corporation has received CE Mark approval for the Accolade pacemaker family. When implanted with the company's Ingevity leads, Accolade pacemakers enable patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems. In addition, the Boston Scientific ImageReady
Successful implantation of microsensor for wireless intraocular pressure measurement in glaucoma patient
Implandata Ophthalmic Products reports the successful implantation of the first patient within the ARGOS-02 clinical study at Augenklinik Bellevue in Kiel, Germany. In the ARGOS-02 clinical study, six eye centers in Germany are currently recruiting primary open angle glaucoma patients, undergoing ca
High-flow polysulfone coupling for healthcare industry
LinkTech Couplings, a supplier of quick couplings and valves is to launch its 60PS series of high-flow couplings made of Udel polysulfone (PSU) resin from Solvay Specialty Polymers for healthcare and industrial applications.
Journal publishes implantable defibrillator trial results
Interim results for the safety and effectiveness of a subcutaneous implantable defibrillator have been published in the European Heart Journal
Long term results from CRT Defibrillator use
Cardiac resynchronisation therapy using CRT defibrillators shows promising results after long term implantation trial
Medical device testing equipment for Israeli hospital
Large private medical facility in Israel chooses advanced testing and analysis equipment for biomedical device calibration
Company activities in cochlear implant market
The activities of companies involved in the global cochlear implants market are examined in a report covering the next four years
Breast implant lab takes implantable identification devices
Implantable device identification technology will be used by Establishment Labs for breast implant tracking
US forecast for implantable medical devices
Market research report examines the implantable medical device market in the USA with forecasts to 2018
Cardiac device supplier added to US Veterans Affairs list
The US department of VA has added cardiac devices from Biotronik to the list of approved suppliers of cardiac rhythm management devices
Breast implant registry to launch in the UK
Device identification and tracking system to be used as part of the new UK breast implant registry for improved patient safety
Spinal implant results show effectiveness in treating chronic pain
Neuromodulation Society event presented with results of tests of the effectiveness in the treatment of chronic pain of the Precision Spectra spinal implant system
Improved walking comfort for stroke patients
ActiGait system is an implantable drop foot simulator for use in stroke patients to improve walking comfort
Award for subcutaneous implantable defibrillator
Boston Scientific has been recognised for best medical technology for its subcutaneous implantable defibrillator
Automated implantable device supply chain management
Two health centres in the USA have chosen XpertSM to automatically manage the supply chain of implantable devices
Infusion pump analyser on show at Medica
Rigel Medical is attending the Medica show with its Multi-Flo infusion pump analyser and other medical devices
Smartphone app for those trained in cardiac resuscitation
An iOS and Android app is available to alert trained personnel to victims of sudden cardiac arrest, shortening response times
Cardiac resuscitation system gains FDA approval
Physio-Control gains FDA approval and the CE Mark on its CodeManagement Module for improving the efficiency of dealing with cardia resuscitation
VeriTeQ receives first order for UDI implantable microchip
Digital Angel, a provider of implantable medical device identification and radiation dose measurement technologies following its recent share exchange with VeriTeQ Acquisition receives the company's first order for its Q Inside implantable microchip for unique device identification (UDI) from Estab
Vanderbilt Heart performs first US implant of AIGISRx R fully bioresorbable antibacterial envelope
The first implantation of TYRX's AIGISRx R Fully Resorbable Antibacterial Envelope takes place at the Vanderbilt Heart and Vascular Institute in Nashville, Tennessee by Dr Christopher Ellis.
Motiva breast implants to use VeriTeQ’s heat-resistant UDI microchip
Digital Angel, a provider of implantable medical device identification and radiation dose measurement technologies following its recent share exchange with VeriTeQ Acquisition, is partnering with Establishment Labs, SA, d/b/a Motiva, to market the world's first traceable breast implant with Q Insid
Medtronic introduces the first neurostimulation systems for chronic pain designed for full-body MRI safety
With the first US implants of its new RestoreSensor SureScan MRI neurostimulation systems, Medtronic is introducing the first and only implantable neurostimulation (also known as spinal cord stimulation, or SCS) systems for use in the treatment of chronic, intractable back and/or limb pain that are
First patient receives L-C Ligament bioresorbable scaffold in EU clinical trial
Soft Tissue Regeneration enrolls the company's first patient in a clinical trial of the company's L-C Ligament, a bioresorbable scaffold for soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee.
TYRX receives FDA clearance for fully resorbable antibacterial envelope
TYRX receives US Food and Drug Administration (FDA) clearance to market the Fully Resorbable AIGISRx R Antibacterial Envelope for use with pacemakers and implantable cardioverter defibrillators (ICDs).
Zero infections in high-risk cardiac device replacements are reported with use of antibacterial envelope
A new study shows the use of TYRX's AIGISRx Antibacterial Envelope reduced major infection rates by 100 percent in patients undergoing Cardiovascular Implantable Electronic Device (CIED) replacement procedures compared to case-matched retrospective control patients.
First implant of Boston Scientific Vitalio pacemaker is performed in Europe
The first patient implant of the Boston Scientific VITALIO pacemaker is performed at ZGT Hengelo in Hengelo, the Netherlands.
St Jude Medical gains CE Mark approval of multipoint pacing CRT-D
St Jude Medical receives CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D).
Study shows deep brain stimulation system improves motor function for patients with Parkinson's disease
Patients with Parkinson's disease using the Boston Scientific's Vercise DBS (deep brain stimulation) System are showing an improvement in motor scores according to interim data from the VANTAGE DBS study.
St Jude Medical receives FDA approval of high-voltage devices with added safety features
St Jude Medical receives US Food and Drug Administration (FDA) approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
St Jude Medical signs agreement to purchase Spinal Modulation
St Jude Medical enters into a series of agreements under which St Jude Medical made a $40 million equity investment in Spinal Modulation, a company that has developed an innovative neuromodulation therapy that provides a new pain management option for patients with chronic, intractable pain.
Antibacterial envelope is shown to reduce major device infection rates by more than 90 percent
Use of TYRX's AIGISRx Antibacterial Envelope is shown to reduce major infection rates by more than 90 percent in patients undergoing Cardiovascular Implantable Electronic Device (CIED) replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study
Sorin Group receives FDA approval for remote monitoring solution for patients with ICDs
Sorin Group receives FDA approval for the SMARTVIEW remote monitoring solution for patients with implanted cardiac rhythm management (CRM) devices and the company is beginning the US launch of the device.
PHRI analysis shows reliability benefits of Optim-insulated defibrillation leads
The Population Health Research Institute (PHRI), an academic health science research institute, has conducted a further independent analysis of data received from ongoing prospective registries that monitor the performance of St Jude Medical's Durata and Riata ST Optim implantable cardioverter defi
St Jude Medical receives CE Mark approval of next-generation implantable defibrillators
St Jude Medical receives CE Mark approval of the company's next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
New Electrophysiology package aims to optimise procedures to improve patient care
Toshiba America Medical Systems is offering clinicians an Infinix-i cardiovascular X-ray system tailored for EP procedures with a new package of features, accessories and technologies to enable accurate and safe exams to be performed.
GHX releases the industry's first implantable devices supply chain solutions for healthcare
GHX is unveiling Case Xpert and Order Intelligence, the healthcare industry's first end-to-end supply chain solutions for managing and tracking implantable medical devices, including the physician preference items (PPI) used in operating rooms.
Biotronik's Ilesto 7 ICD/CRT-D series receives US FDA approval
The Food and Drug Administration (FDA) grants approval for Biotronik's Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) series.
Medtronic receives FDA approval of next-generation CRT-D and ICD devices
Medtronic receives US Food and Drug Administration (FDA) approval for the company's newest cardiac devices:
the Viva portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices, and the Evera portfolio of implantable cardioverter-defibrillators (ICD).
Boston Scientific acquires Fixate tissue band for spinal cord stimulator leads and pain pump catheters
Boston Scientific acquires the fiXate Tissue Band and is launching the product in the USA.
Boston Scientific receives US FDA approval for spinal cord stimulator system
Boston Scientific receives approval by the US Food and Drug Administration and is beginning a limited launch of the Precision Spectra Spinal Cord Stimulator (SCS) System.
Thoracic-length Heli-FX Aortic securement system receives CE Mark
Aptus Endosystems receives CE clearance for the company's thoracic-length Heli-FX System. Similar to the original Heli-FX system that was cleared for European distribution in May 2011 and designed for treating abdominal aortic aneurysms (AAA), the new system consists of a longer delivery device wit
Abiomed enrolls first patient in percutaneous heart pump study
Abiomed enrolls the first patient in RECOVER RIGHT, an Investigational Device Exemption (IDE) study of Impella RP (Right Peripheral).
UK educational roadshow kicks focuses on innovations in gait rehabilitation
Ottobock is launching a UK-wide educational tour to promote the latest technical innovations in gait rehabilitation.
US FDA grants approval to first single-lead ICD with atrial sensing
The US Food and Drug Administration (FDA) is granted final approval for the Biotronik Lumax 740 DX System which a first-in-class implantable cardiac defibrillator (ICD) that utilises a single lead with atrial sensing capabilities.
Tigre deploys ZOLL CPR units to become the first heart safe city in Argentina
The city of Tigre in the Province of Buenos Aires, installs ZOLL AED Plus units in public areas throughout the popular tourist destination, making it the first Heart Safe City in Argentina.
High-density, long-length, continuous cables deliver signal transmission benefits for implantable medical devices
Molex is introducing the company's MediSpec High-Density Micro-Ribbon Cables which replace individual primary wires and flexible circuits with ribbonized parallel wires bonded together using fluoropolymer technology into an organized, dense package for ease-of-routing and electrical length matching
Fully automatic AED Plus receives 510(k) clearance by US FDA
ZOLL Medical receives 510(k) clearance from the US Food and Drug Administration to market and begin US distribution of the new fully automatic version of the ZOLL AED Plus.
Defibrillator manufacturer pledges to make patient data available to reduce preventable deaths
ZOLL Medical becomes the first major defibrillator manufacturer to publicly pledge the sharing of patient data to reduce preventable deaths.
St Jude Medical receives US FDA approval of new version of remote patient monitoring system
St Jude Medical receives US Food and Drug Administration (FDA) approval of the next-generation Merlin.net Patient Care Network (PCN), a secure, Internet-based remote care system for patients with implanted medical devices.
First | Prev  | 1 | 2 | 3 | 4 | 5 | 6 | 7  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo